Login / Signup
Tarek Bou Dargham
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Phase Ii Study
Epidermal Growth Factor Receptor
Neoadjuvant Chemotherapy
Sentinel Lymph Node
Top Venues
Current oncology (Toronto, Ont.)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hikmat Abdel-Razeq
,
Hanan Khalil
,
Hazem I Assi
,
Tarek Bou Dargham
Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer.
Current oncology (Toronto, Ont.)
29 (8) (2022)